Health TrialsbyHealthPanel

Digital Peer Navigation for Adolescents and Young Adults With Cancer

ConditionsLymphomaBreast CancerTesticular CancerSarcoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity Health Network, Toronto

About this trial

Adolescents and young adults (AYA) diagnosed with cancer experience unique challenges after completing treatment and face distinct barriers to optimal care and support. These challenges include higher levels of symptom burden and treatment complications, interrupted education, careers and relationships, and financial hardship. AYA lack access to peers, relevant information and emotional support, and report gaps in care when dealing with these difficult challenges.

Digital peer navigation could help to address the needs of AYA and overcome barriers to care and support. The PI developed True North Peer Navigation (TrueNTH-PN), an evidence-based digital peer navigation program for men with prostate cancer and online peer navigator training course. The goal of this project is to adapt TrueNTH-PN for AYA and evaluate its feasibility to overcome barriers to care and support, and enhance patient activation among AYA during the challenging post-treatment phase.

In partnership with AYA cancer survivors, the Canadian Cancer Society, Young Adult Cancer Canada, a digital app design firm and technology provider, our cross-Canada team will: (1) Adapt and evaluate the usability of the TrueNTH-PN app for AYA; (2) Adapt and evaluate the effectiveness of the Peer Navigator Training Course for AYA; and (3) Determine the feasibility, acceptability and preliminary effectiveness of the new AYA-PN program among post-treatment AYA cancer survivors.

This project will produce an innovative solution to an important service gap in the lives of AYA with cancer. It has the potential to address the support needs of AYA, overcome barriers to care, and empower AYA to take proactive role in managing their health. In addition, it will give rise to AYA peer navigators with specialized skills, which could fill gaps in disrupted education and career paths, and help to attain future goals.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Are 18-40 years old;

Were diagnosed with breast or testicular cancer, lymphoma or sarcoma between the ages of 15-39 years old;

Have completed therapy within the last 12 months;

Are comfortable using the internet;

Disqualifiers

Have metastatic disease or are receiving palliative end-of-life care;

Are not willing to be randomized.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Digital Peer Navigation

    Behavioral

    Participants in the intervention group will receive ongoing support from a trained peer navigator for 3 months after completing treatment for cancer. Participants will be matched through a digital app with a trained peer navigator who assesses needs and barriers to care, provides practical, informational, and emotional support, and empowers them to take a proactive role in their health. Patients will communicate with their peer navigator through digital direct messaging, videoconference or by telephone. Participants will also have access to a health resource library on the digital app that contains local and national resources about cancer.

Treatment groups

138 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: Waitlist ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Patient activation

The primary outcome will be change in Patient Activation from baseline to 3 months. Patient Activation will be measured using the Patient Activation Measure (PAM). Higher scores represent a better outcome.

Time frame
0, 3 months

Secondary outcomes

1

Health utility

Health utility will be measured with the EQ-5D.

Time frame
0, 3 months
2

Supportive care needs

Supportive care needs will be measured with the Supportive Care Needs Survey (SCNS-SF34).

Time frame
0, 3 months
3

Anxiety

Anxiety will be measured with the Generalized Anxiety Disorder scale (GAD-7).

Time frame
0, 3 months
4

Depression

Depression will be measured with the Patient Health Questionnaire (PHQ-9).

Time frame
0, 3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Health Network, Toronto

Lead sponsor

Canadian Cancer Society (CCS)

Collaborator

Young Adult Cancer Canada

Collaborator

Source ClinicalTrials.gov
Apply now